5-FU 45 Gy 5-F*U 5-FU. OS: 27 months vs 36 months. Time to relapse: 19 vs 30 months ... Epirubicin, cisplatin, 5-FU (ECF) Surg. vs 3 x ECF Surgery 3 x ECF ...
QUEL BILAN D IMAGERIE A L ERE DES TRAITEMENTS NEO-ADJUVANTS ? Marc Zins Groupe hospitalier Paris Saint-Joseph La SIAD. Imagerie en canc rologie digestive.
... in situ is suspected (positive cytology in absence of gross tumors) random ... cytology cystoscopy & TUR every 3 months. Treatment. Recurrent superficial cases : ...
Modern and Evolving Modalities of Lung Cancer Treatment Mr Vladimir Anikin Consultant Thoracic Surgeon Harefield Hospital, London UK LungTSSGMeetingMay2013Lister ...
New Aspects of Adjuvant Therapy in Endometrial Cancer: Current Standards ... These patients may benefit from adjuvant platinum-based chemotherapy utilized to ...
... obstructive jaundice and abdominal discomfort Diagnosis of Cholangiocarcinoma CCA is slow growing tumor that invades adjacent neural, lymphatic and hepatic tissue.
Randomized study comparing neoadjuvant chemotherapy Etoposide Ifosfamide ... carcinoma of the cervix, by an upload by brachytherapy; a phase II-study ...
... all new cancer patients announced in the previous calendar year. ... Country of birth, citizenship & mother tongue of the population. Multi-cultural Hungary ...
... Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group ... oropharynx: results of Eastern Cooperative Oncology Group Study E2399. ...
Rituxan after Auto. Rituximab after auto SCT in pts with MRD ... Auto vs. Allo. Relapses. Treatment related mortality ... 'Accessory' cells may dictate outcome ...
Einf hrung in die schulmedizinische Tumortherapie der menschliche K rper besteht aus 100 Billionen Zellen eine 1 mit 14 Nullen 100.000.000.000.000 beim einem ...
No protecting effect of Amifostine (A) on acute toxicity of chemoradiation in ... upper normal limit of testing laboratory, SGOT, SGPT 3 times upper normal limit ...
... in the area of oesophageal and rectal cancer at St. James's Hospital, Dublin. ... from cancer patients undergoing neoadjuvant radiochemotherapy in rectal or ...